Discussion Question

Discussion Question

Salbutamol is among the medications used to treat asthma and other conditions causing bronchoconstriction. Salbutamol is used to relieve the symptoms characterized by wheezing, coughing, and dyspnoea (Usmani, 2019). The medication works by relieving the relaxing the airway muscles and thus easing breathe. The common side effects of salbutamol include increased heartbeat, headache, sore throat and cough, sleep disturbances, and dry mouth. Patients should be monitored closely for heart rate and arrhythmias. It is important to consider the patients cardiovascular system’s functioning before prescribing the medication because patients with heart failure may not respond positively to the medication. Similarly, people with repeated pneumonia should not be given. The medication is found under the bronchodilators in the COPD guideline (Patel et al., 2019). Furthermore, the disturbance in the sleeping pattern could exacerbate the irregular heartbeat and this could be dangerous for the patients. The vitals must also be monitored. The goal in medication administration is to ease the difficulties in breathing.

The salbutamol interacts with antipsychotic medications such as clozapine and amphetamines. Also, the medication is safe in pregnancy considering that it is inhaled and so most of it gets into the lung rather than the blood. The drug is used as the first-line treatment for people with bronchoconstriction because of the limited side effects it has on the patients. A large population group can benefit from the drug.

The study by Xu et al. (2020) indicated that salbutamol reduces the risk for hospitalization among patients with asthma and COPD. Also, the therapeutic outcomes were more significant when the medication was administered alongside ipratropium. The findings provide sufficient evidence to support the use of salbutamol in managing COPD and asthma because a large sample population was included in the 1061 studies reviewed. The study confirms a positive interaction between salbutamol and ipratropium. It also offers the treatment guideline that adults should receive a dosage of 4mg TDS or QID while children should be given 2mg TDS.

ORDER A PLAGIARISM-FREE PAPER HERE

References

Patel, A. R., Patel, A. R., Singh, S., Singh, S., & Khawaja, I. (2019). Global initiative for chronic obstructive lung disease: the changes made. Cureus, 11(6).https://goldcopd.org/wp-content/uploads/2020/11/GOLD-2021-POCKET-GUIDE-v1.0-16Nov20_WMV.pdf

Usmani, O. S. (2019). Choosing the right inhaler for your asthma or COPD patient. Therapeutics and Clinical Risk Management, 15, 461-472. https://doi.org/10.2147/tcrm.s160365

Xu, H., Tong, L., Gao, P., Hu, Y., Wang, H., Chen, Z., & Fang, L. (2020). Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis. https://doi.org/10.1101/2020.07.31.230318

please answer discussion question, minimum 250 words thank you

Select a medication and apply evidence or treatment guidelines used for the treatment of asthma, COPD, or an acute exacerbation of COPD. Share the mechanism of action of this medication and hints for monitoring, side effects, and drug interactions, including interactions with CAM. Integrate information regarding where the medication is found in asthma or COPD guidelines. What other considerations need to be made when prescribing these medications in relation to other systems and receptors? Discuss evidence and treatment guidelines to determine appropriate therapeutic options for a patient with respiratory disorders. Include the name of the medication in the subject line so that the medications can be followed. Include references using APA format